| scholarly article | Q13442814 |
| P50 | author | Wolfgang Langhans | Q58213591 |
| P2093 | author name string | Harvey J Grill | |
| Matthew R Hayes | |||
| Theresa M Leichner | |||
| Bart C De Jonghe | |||
| Scott E Kanoski | |||
| Myrtha Arnold | |||
| Amber L Alhadeff | |||
| Samantha M Fortin | |||
| P2860 | cites work | The epidemiology of obesity | Q57196005 |
| An anterograde tracing study of the vagal innervation of rat liver, portal vein and biliary system | Q67464352 | ||
| Effect of highly selective vagotomy on gastric emptying | Q68222119 | ||
| Specific postoperative syndromes after total and selective vagotomies in the rat | Q70041704 | ||
| The route of absorption of intraperitoneally administered compounds | Q71828308 | ||
| Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1 | Q71836400 | ||
| The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-1, but not to glucose-dependent insulinotropic polypeptide, in the portal vein | Q71840049 | ||
| Capsaicin and nociception in the rat and mouse. Possible role of substance P | Q72679718 | ||
| Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms | Q72998037 | ||
| Capsaicin-resistant vagal afferent fibers in the rat gastrointestinal tract: anatomical identification and functional integrity | Q73083230 | ||
| Vagal afferent innervation of smooth muscle in the stomach and duodenum of the mouse: morphology and topography | Q73179701 | ||
| Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin | Q73317012 | ||
| The hepatic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP-1 receptor | Q73608186 | ||
| Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat | Q79301454 | ||
| Vagal innervation of intestines: afferent pathways mapped with new en bloc horseradish peroxidase adaptation | Q80203316 | ||
| Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats | Q93642503 | ||
| The Physiology of Glucagon-like Peptide 1 | Q28373115 | ||
| Gastric emptying of liquids after different vagotomies and pyloroplasty | Q30111667 | ||
| Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice | Q33196495 | ||
| Post-oral infusion sites that support glucose-conditioned flavor preferences in rats | Q33620979 | ||
| Opioid mediation of starch and sugar preference in the rat | Q34091948 | ||
| Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4. | Q35110843 | ||
| Gastrointestinal mechanisms of satiation for food | Q35781867 | ||
| A method for selective section of vagal afferent or efferent axons in the rat | Q36676390 | ||
| Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation | Q36796571 | ||
| Effect of intraperitoneal and intravenous administration of cholecystokinin-8 and apolipoprotein AIV on intestinal lymphatic CCK-8 and apo AIV concentration. | Q37086397 | ||
| Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms | Q37125945 | ||
| Incretin-based therapies for type 2 diabetes mellitus | Q37483473 | ||
| Role of the glucagon-like-peptide-1 receptor in the control of energy balance | Q37708356 | ||
| Liraglutide: the therapeutic promise from animal models. | Q37795871 | ||
| Nutrient sensing in the gut: interactions between chemosensory cells, visceral afferents and the secretion of satiation peptides | Q37849883 | ||
| Sensing via intestinal sweet taste pathways | Q37868939 | ||
| Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage | Q40035788 | ||
| Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats | Q40116707 | ||
| Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat. | Q42453890 | ||
| Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion | Q42469854 | ||
| Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study | Q43255700 | ||
| Flavor preferences conditioned by intragastric fructose and glucose: differences in reinforcement potency | Q43597526 | ||
| Selective effects of vagal deafferentation and celiac-superior mesenteric ganglionectomy on the reinforcing and satiating action of intestinal nutrients | Q44308075 | ||
| Leptin-induced satiation mediated by abdominal vagal afferents | Q45182797 | ||
| The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway | Q46464837 | ||
| CCK enhances response to gastric distension by acting on capsaicin-insensitive vagal afferents | Q46499650 | ||
| Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice | Q46525214 | ||
| Chemotherapy-induced pica and anorexia are reduced by common hepatic branch vagotomy in the rat. | Q46815780 | ||
| The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size. | Q47282831 | ||
| Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not. | Q47308234 | ||
| Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes | Q47333592 | ||
| Is there a role for the liver in the control of food intake? | Q48438811 | ||
| Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. | Q48599985 | ||
| Retrograde tracer technique for assessment of selective and total subdiaphragmatic vagotomies. | Q50901724 | ||
| Afferent innervation of gastrointestinal tract smooth muscle by the hepatic branch of the vagus | Q52259345 | ||
| The fiber composition of the abdominal vagus of the rat. | Q53889988 | ||
| The functional involvement of gut-expressed sweet taste receptors in glucose-stimulated secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) | Q57120477 | ||
| P433 | issue | 5 | |
| P304 | page(s) | R1479-85 | |
| P577 | publication date | 2011-08-17 | |
| P1433 | published in | American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | Q2201819 |
| P1476 | title | The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1. | |
| P478 | volume | 301 |
| Q41210530 | Activation of Short and Long Chain Fatty Acid Sensing Machinery in the Ileum Lowers Glucose Production in Vivo |
| Q64069028 | Adenosine triphosphate is co-secreted with glucagon-like peptide-1 to modulate intestinal enterocytes and afferent neurons |
| Q35991683 | Brain GLP-1 and insulin sensitivity |
| Q48577648 | Brain processing of duodenal and portal glucose sensing |
| Q47356509 | Central GLP-1 receptor activation modulates cocaine-evoked phasic dopamine signaling in the nucleus accumbens core |
| Q51316347 | Does the hepatic branch of vagus mediate the secretion of glucagon-like peptide-1 during the Roux-en-Y gastric bypass surgery? |
| Q41449397 | Exogenous glucagon-like peptide-1 acts in sites supplied by the cranial mesenteric artery to reduce meal size and prolong the intermeal interval in rats |
| Q57037977 | Fasting glucagon-like peptide 1 concentration is associated with lower carbohydrate intake and increases with overeating |
| Q38794234 | GLP-1 and weight loss: unraveling the diverse neural circuitry |
| Q38238288 | GLP-1: benefits beyond pancreas. |
| Q39047697 | Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB. |
| Q92129722 | Glucagon, GLP-1 and Thermogenesis |
| Q35243151 | Gut microbiota, nutrient sensing and energy balance |
| Q39728657 | Hexosamine biosynthetic pathway activity in leptin resistant sucrose-drinking rats |
| Q37727577 | Hormonal signaling in the gut. |
| Q38072203 | Incretin hormones and the satiation signal. |
| Q35690970 | Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose |
| Q37578125 | Intraduodenal milk protein concentrate augments the glycemic and food intake suppressive effects of DPP-IV inhibition |
| Q42091122 | Liraglutide suppresses the plasma levels of active and des-acyl ghrelin independently of active glucagon-like Peptide-1 levels in mice |
| Q54939638 | Meal-Sensing Signaling Pathways in Functional Dyspepsia. |
| Q36902607 | Mercaptoacetate blocks fatty acid-induced GLP-1 secretion in male rats by directly antagonizing GPR40 fatty acid receptors. |
| Q89533632 | Metabolic Effect of the Hepatic Branch of the Vagal Nerve in One-Anastomosis Gastric Bypass (OAGB) |
| Q30412673 | Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect |
| Q37988231 | Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects |
| Q36339320 | PPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation. |
| Q36166645 | Peripheral neural targets in obesity |
| Q27027920 | Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease |
| Q91121478 | Physiology of the Incretin Hormones, GIP and GLP-1-Regulation of Release and Posttranslational Modifications |
| Q35834277 | Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota |
| Q34356012 | Role of capsaicin-sensitive peripheral sensory neurons in anorexic responses to intravenous infusions of cholecystokinin, peptide YY-(3-36), and glucagon-like peptide-1 in rats |
| Q36317400 | Roux-en-Y gastric bypass operation in rats. |
| Q87842301 | Signalling from the periphery to the brain that regulates energy homeostasis |
| Q38304318 | Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents |
| Q38812536 | The Role of the Vagal Nucleus Tractus Solitarius in the Therapeutic Effects of Obesity Surgery and Other Interventional Therapies on Type 2 Diabetes. |
| Q30596646 | The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss |
| Q38123372 | The endocrinology of food intake |
| Q38031993 | The interaction of amylin with other hormones in the control of eating |
| Q91304787 | The metabolic role of vagal afferent innervation |
| Q47347620 | Vagal afferents mediate early satiation and prevent flavour avoidance learning in response to intraperitoneally infused exendin-4. |
Search more.